Showing results (461-470 of 530) with videos related to
Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.JTCVS Open|July 9, 2025
The implementation of an electronic symptom management system to monitor postoperative pain in thoracic surgery patients: A multicenter evaluationJorind Beqari, Jacob Hurd, Angela C Tramontano, et al.European Heart Journal|June 27, 2025
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysisFaizan Khan, Tobias Tritschler, Caterina E Marx, et al.Cancer Research Communications|February 8, 2024
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer RegistryEnrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, et al.Journal of the National Cancer Institute|August 1, 2022
Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)Jessica R Schumacher, Heather B Neuman, Menggang Yu, et al.JCO Precision Oncology|February 9, 2022
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United StatesAndrew N Freedman, Carrie N Klabunde, Kristine Wiant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIEMichele L LeNoue-Newton, Sheau-Chiann Chen, Thomas Stricker, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.Pageof 53